Calmangafodipir for prevention of oxaliplatin-induced peripheral neuropathy: two placebo-controlled, randomized phase 3 studies (polar-a/polar-m)
HIGHLIGHTS who: JNCI Cancer Spectrum ( and colleagues from the DepartmentOdense University, Nagoya, Japan have published the paper: Calmangafodipir for […]